| Associated Eye Care, P.a. | |
|
272 Cottage St, Sanford, ME 04073-1815 | |
| (207) 324-8888 | |
| (207) 636-5023 |
| Full Name | Associated Eye Care, P.a. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 272 Cottage St, Sanford, Maine |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144245150 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | William T Kirn |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1285659417 PECOS PAC ID: 1658315312 Enrollment ID: I20050719000655 |
News Archive
Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.
Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.
› Verified 5 days ago
| Provider Name | Amy M Abbott |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1578663365 PECOS PAC ID: 5294766093 Enrollment ID: I20060317000352 |
News Archive
Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.
Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.
› Verified 5 days ago
| Provider Name | David L Lavoie |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1942229398 PECOS PAC ID: 5799793105 Enrollment ID: I20060327000769 |
News Archive
Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.
Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.
› Verified 5 days ago
| Provider Name | Sara M Gordon |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1902046808 PECOS PAC ID: 7719041755 Enrollment ID: I20090205000454 |
News Archive
Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.
Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.
› Verified 5 days ago
| Provider Name | Naila Aslam |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1265480958 PECOS PAC ID: 2668640947 Enrollment ID: I20120531000454 |
News Archive
Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.
Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.
› Verified 5 days ago
| Provider Name | Lindsey M Jendrasko |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1144509654 PECOS PAC ID: 2769631977 Enrollment ID: I20121003000708 |
News Archive
Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.
Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.
› Verified 5 days ago
| Provider Name | Sasha L Bishop |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1174823884 PECOS PAC ID: 9032343801 Enrollment ID: I20131010000038 |
News Archive
Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.
Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.
› Verified 5 days ago
| Provider Name | Briana Mcandrew |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1295138600 PECOS PAC ID: 6507179363 Enrollment ID: I20150722005274 |
News Archive
Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.
Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.
› Verified 5 days ago
| Provider Name | Alexandra Rae Grotton |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1447600986 PECOS PAC ID: 4385937531 Enrollment ID: I20160726000359 |
News Archive
Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.
Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.
› Verified 5 days ago
| Provider Name | Ryan M Carr |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1689168189 PECOS PAC ID: 4284983099 Enrollment ID: I20180827003200 |
News Archive
Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.
Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.
› Verified 5 days ago
| Provider Name | Kelsey Renee Wilson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1083291454 PECOS PAC ID: 5294137030 Enrollment ID: I20210715002290 |
News Archive
Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.
Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.
› Verified 5 days ago
| Provider Name | Noah John Boutin |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1366013740 PECOS PAC ID: 0547649287 Enrollment ID: I20220627000607 |
News Archive
Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.
Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Associated Eye Care, P.a. 272 Cottage St, Sanford, ME 04073-1815 Ph: (207) 324-8888 | Associated Eye Care, P.a. 272 Cottage St, Sanford, ME 04073-1815 Ph: (207) 324-8888 |
News Archive
Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.
Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.
› Verified 5 days ago
Dr. Daniel P. Roy, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1110 Main St, Sanford, ME 04073 Phone: 207-324-6281 Fax: 207-324-7143 | |
Kelsey Wilson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 272 Cottage St, Sanford, ME 04073 Phone: 207-324-8888 Fax: 207-490-1716 | |
Dr. Lindsey Marie Jendrasko, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 272 Cottage St, Sanford, ME 04073 Phone: 207-324-8888 Fax: 207-490-1716 | |
Dr. Sasha Lynn Bishop, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 272 Cottage St, Sanford, ME 04073 Phone: 207-324-8888 Fax: 207-490-1716 | |
Dr. Ronald Dennis Roy, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 890 Main St, Suite 204, Sanford, ME 04073 Phone: 207-324-0400 | |
William T. Kirn, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 272 Cottage St, Sanford, ME 04073 Phone: 207-324-8888 |